Company · CIK 1472091
PDS Biotechnology Corp
| CIK | 1472091 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NJ |
| Listed | PDSB (Nasdaq) |
| First annual or quarterly report | 2015-11-06 |
Offerings
10 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-299455 | 2026-10-14 | 2026-10-14 | 1 | |
| 333-297386 | 2026-07-10 | 2026-07-21 | 3 | |
| 333-289942 | 2025-08-29 | 2026-06-15 | 3 | |
| 333-267041 | 2022-08-24 | 2025-11-12 | 5 | |
| 333-287588 | 2025-05-27 | 2025-06-10 | 2 | |
| 333-240011 | 2020-07-22 | 2021-06-16 | 5 | |
| 333-235549 | 2019-12-17 | 2020-02-12 | 5 | |
| 333-232988 | 2019-08-02 | 2019-08-28 | 3 | |
| 333-214196 | 2016-10-21 | 2017-04-19 | 3 | |
| 333-206416 | 2015-08-14 | 2015-10-02 | 4 |
Filings
35| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-10-14 | S-3Shelf registered | 333-299455 | 0001140361-26-039595 |
| 2026-07-21 | EFFECTDeclared effective | 333-297386 | 9999999995-26-002373 |
| 2026-07-21 | 424B4Final prospectus | 333-297386 | 0001140361-26-029135 |
| 2026-07-10 | S-3Shelf registered | 333-297386 | 0001140361-26-028217 |
| 2026-06-15 | 424B5Shelf takedown | 333-289942 | 0001140361-26-025227 |
| 2026-04-28 | EFFECTDeclared effective | 333-289942 | 9999999995-26-001350 |
| 2025-11-12 | 424B5Shelf takedown | 333-267041 | 0001140361-25-041557 |
| 2025-08-29 | S-3Shelf registered | 333-289942 | 0001140361-25-033423 |
| 2025-06-10 | EFFECTDeclared effective | 333-287588 | 9999999995-25-001882 |
| 2025-05-27 | S-3Shelf registered | 333-287588 | 0001140361-25-020483 |
| 2025-02-28 | 424B5Shelf takedown | 333-267041 | 0001140361-25-006377 |
| 2024-08-13 | 424B5Shelf takedown | 333-267041 | 0001140361-24-037090 |
| 2022-09-02 | EFFECTDeclared effective | 333-267041 | 9999999995-22-002580 |
| 2022-08-24 | S-3Shelf registered | 333-267041 | 0001140361-22-030726 |
| 2021-06-16 | 424B5Shelf takedown | 333-240011 | 0001140361-21-021265 |
| 2021-06-14 | 424B5Shelf takedown | 333-240011 | 0001140361-21-020834 |
| 2020-08-10 | 424B5Shelf takedown | 333-240011 | 0001140361-20-017981 |
| 2020-07-31 | EFFECTDeclared effective | 333-240011 | 9999999995-20-001995 |
| 2020-07-22 | S-3Shelf registered | 333-240011 | 0001140361-20-016532 |
| 2020-02-12 | 424B4Final prospectus | 333-235549 | 0001140361-20-002968 |
| 2020-02-11 | EFFECTDeclared effective | 333-235549 | 9999999995-20-000316 |
| 2020-01-31 | S-1/AAmendment | 333-235549 | 0001140361-20-001970 |
| 2020-01-17 | S-1/AAmendment | 333-235549 | 0001567619-20-001206 |
| 2019-12-17 | S-1Registration filed | 333-235549 | 0001140361-19-022730 |
| 2019-08-28 | EFFECTDeclared effective | 333-232988 | 9999999995-19-001982 |
| 2019-08-20 | S-1/AAmendment | 333-232988 | 0001140361-19-015390 |
| 2019-08-02 | S-1Registration filed | 333-232988 | 0001140361-19-014132 |
| 2017-04-19 | 424B5Shelf takedown | 333-214196 | 0001567619-17-000693 |
| 2016-11-02 | EFFECTDeclared effective | 333-214196 | 9999999995-16-006137 |
| 2016-10-21 | S-3Shelf registered | 333-214196 | 0001567619-16-003088 |
| 2015-10-02 | 424B4Final prospectus | 333-206416 | 0001567619-15-001318 |
| 2015-09-30 | EFFECTDeclared effective | 333-206416 | 9999999995-15-002632 |
| 2015-09-21 | S-1/AAmendment | 333-206416 | 0001567619-15-001209 |
| 2015-08-14 | S-1Registration filed | 333-206416 | 0001567619-15-001095 |
| 2014-03-21 | DRSDraft made public | 377-00526 | 0001567619-14-000130 |